JPMORGAN CHASE & CO - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637H909. A total of 4 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$2,845
-99.9%
50,000
-50.0%
0.00%
-100.0%
Q3 2022$3,954,000
-30.3%
100,000
-22.5%
0.00%0.0%
Q2 2022$5,676,000
-8.4%
129,000
-17.0%
0.00%0.0%
Q1 2022$6,197,000
+392.2%
155,400
+414.6%
0.00%
Q1 2021$1,259,000
-88.0%
30,200
-92.4%
0.00%
-100.0%
Q3 2020$10,519,000
+732.2%
396,800
+429.1%
0.00%
Q2 2019$1,264,000
+161.7%
75,000
+150.0%
0.00%
Q1 2019$483,000
+10.0%
30,0000.0%0.00%
Q4 2018$439,000
+38.9%
30,000
+92.3%
0.00%
Q4 2017$316,000
-74.6%
15,600
-89.2%
0.00%
Q2 2016$1,246,000144,4000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 27,600$1,101,0000.00%
JPMORGAN CHASE & CO 155,400$6,197,0000.00%
SIMPLEX TRADING, LLC 5,500$219,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of HALOZYME THERAPEUTICS INC shareholders